mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
0.17 |
0.3 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |